Non-invasive prenatal testing (NIPT) using cell-free DNA for aneuploidy is a highly accurate screening test; however, concerns exist around the potential for routinisation of testing. The ...
BALTIMORE--(BUSINESS WIRE)--Gateway Genomics demonstrates the accuracy of its advanced prenatal technology in a validation study showcased at the American Society of Human Genetics Conference. After ...
Growing market expected to reach $3.6 billion by 2019. Prenatal screening for detection of a wide range of monogenic disorders and chromosomal abnormalities has been available to prospective parents ...
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033" report has been ...
The Non-Invasive Prenatal Testing (NIPT) market is on track to exceed USD 4 billion across the 15 major markets (15MM) by the end of 2021. This reflects a significant increase from its valuation of ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Sept. 2, 2024 /PRNewswire/ -- The global Non-invasive Prenatal Testing (NIPT) Market is valued at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results